Consolidated revenue from operations increased nearly 7% YoY to Rs 9,182.31 crore, but was lower than the estimated Rs 9,358 crore. The paint maker’s operating profit increased by 36.3% YoY to Rs 2,121.3 crore, with gross margins expanding a whopping 530 basis points (bps) in the quarter.
AstraZeneca Pharma shares rally 13%, hit 52-week high after receiving nod for cancer drug Durvalumab
AstraZeneca Pharma Share Price: The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages (SMAs).